{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:52:09Z","timestamp":1790326329585,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.esmoop.2022.100560","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T13:33:41Z","timestamp":1660829621000},"page":"100560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries"],"prefix":"10.1016","volume":"7","author":[{"given":"R.","family":"Soo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bardot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kanesvaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Keong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pongnikorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Prasongsook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Hutajulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Irawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ab","family":"Manan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sripan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Stahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2022.100560_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2022.100560_bib2","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2020"},{"issue":"7010","key":"10.1016\/j.esmoop.2022.100560_bib3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group","volume":"311","year":"1995","journal-title":"BMJ"},{"issue":"28","key":"10.1016\/j.esmoop.2022.100560_bib4","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","article-title":"Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials","volume":"26","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.esmoop.2022.100560_bib6","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100560_bib7","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2014.59.4424","article-title":"BEYOND: a randomized, double-blind, placebo-controlled, multicenter, phase III study of first-line carboplatin\/paclitaxel plus bevacizumab or placebo in Chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer","volume":"33","author":"Zhou","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.esmoop.2022.100560_bib8","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2022.100560_bib9","unstructured":"The ESMO Guidelines Committee, Clinical Practice Living Guidelines \u2013 Metastatic Non-Small-Cell Lung Cancer | ESMO. 2020, European Society for Medical Oncology."},{"issue":"suppl 4","key":"10.1016\/j.esmoop.2022.100560_bib10","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2022.100560_bib11","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","article-title":"Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Novello","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100560_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2022.100560_bib13","article-title":"NEJ026: final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations","volume":"38","author":"Maemondo","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100560_bib14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100560_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jtho.2018.12.014","article-title":"Natural history and factors associated with overall survival in stage IV ALK-rearranged non-small cell lung cancer","volume":"14","author":"Pacheco","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.esmoop.2022.100560_bib16","series-title":"International classification of diseases for oncology (ICD-O)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.esmoop.2022.100560_bib17","series-title":"Cancer Incidence in Five Continents Volume XI","author":"Bray","year":"2021"},{"key":"10.1016\/j.esmoop.2022.100560_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2019.11.022","article-title":"Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: incremental yield of actionable alterations and cost-effectiveness analysis","volume":"139","author":"Tan","year":"2020","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100560_bib19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s12325-018-0811-0","article-title":"Treatment patterns by EGFR mutation status in non-small cell lung cancer patients in the USA: a retrospective database analysis","volume":"35","author":"Aguilar","year":"2018","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100560_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/JTO.0b013e31828916aa","article-title":"Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer","volume":"8","author":"Berry","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100560_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.athoracsur.2014.03.001","article-title":"Quality indicators for non-small cell lung cancer operations with use of a modified Delphi consensus process","volume":"98","author":"Darling","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.esmoop.2022.100560_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2017.12.013","article-title":"Patterns of treatment and survival among older patients with stage III non-small cell lung cancer","volume":"116","author":"Driessen","year":"2018","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100560_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156728","article-title":"Real-world patterns of EGFR testing and treatment with erlotinib for non-small cell lung cancer in the United States","volume":"11","author":"Enewold","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100560_bib24","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.21037\/jtd.2018.09.141","article-title":"Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis","volume":"10","author":"Furqan","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100560_bib25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/JTO.0b013e3182a4070f","article-title":"Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry","volume":"8","author":"Jakobsen","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100560_bib26","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.athoracsur.2017.06.065","article-title":"Patterns of treatment and outcomes for definitive therapy of early stage non-small cell lung cancer","volume":"104","author":"Kapadia","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3747\/co.23.2789","article-title":"Identification of performance indicators across a network of clinical cancer programs","volume":"23","author":"Khare","year":"2016","journal-title":"Curr Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100560_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/0284186X.2017.1324213","article-title":"The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study","volume":"56","author":"Nilsson","year":"2017","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100560_bib29","first-page":"3979","article-title":"Patients with non-small cell lung cancer analyzed for EGFR: adherence to guidelines, prevalence and outcome","volume":"35","author":"Sandelin","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.esmoop.2022.100560_bib30","series-title":"Lung Cancer Clinical Quality Performance Indicators","year":"2017"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100560_bib31","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.cllc.2016.11.002","article-title":"Utilization patterns and trends in epidermal growth factor receptor (EGFR) mutation testing among patients with newly diagnosed metastatic lung cancer","volume":"18","author":"Shen","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijrobp.2014.01.033","article-title":"Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution","volume":"89","author":"Sher","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/apm.12328","article-title":"The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population","volume":"123","author":"Skov","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.esmoop.2022.100560_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00408-014-9603-8","article-title":"The Victorian Lung Cancer Registry Pilot: improving the quality of lung cancer care through the use of a disease quality registry","volume":"192","author":"Stirling","year":"2014","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100560_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpainsymman.2017.10.009","article-title":"Impact of targeted therapy on the quality of end-of-life care for patients with non-small-cell lung cancer: a population-based study in Taiwan","volume":"55","author":"Tsai","year":"2018","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.esmoop.2022.100560_bib36","series-title":"Quality Indicators for the Management of Lung Cancer","author":"Vrijens","year":"2016"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100560_bib37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12885-017-3602-0","article-title":"Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100560_bib38","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.25616","article-title":"Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study","volume":"117","author":"Wu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2022.100560_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.esmoop.2022.100560_bib40","series-title":"Planning and developing population-based cancer registration in low- and middle-income settings","author":"Bray","year":"2014"},{"key":"10.1016\/j.esmoop.2022.100560_bib41","series-title":"IARC- Check and conversion Program. IARC Technical Report No. 42","author":"Ferlay","year":"2005"},{"key":"10.1016\/j.esmoop.2022.100560_bib42","series-title":"TNM Classification of Malignant Tumours","first-page":"272","year":"2016"},{"key":"10.1016\/j.esmoop.2022.100560_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1741-7015-12-3","article-title":"Managing the changing burden of cancer in Asia","volume":"12","author":"Sankaranarayanan","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.esmoop.2022.100560_bib44","series-title":"Price Setting and Price Regulation in Health Care: Lessons for Advancing Universal Health Coverage","first-page":"219","article-title":"Organisation for Economic Co-operation and Development","year":"2019"},{"key":"10.1016\/j.esmoop.2022.100560_bib45","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s12325-022-02189-z","article-title":"Real-world patient characteristics, treatment patterns, and mutation testing patterns among US patients with advanced non-small cell lung cancer Harboring EGFR mutations","volume":"39","author":"He","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.esmoop.2022.100560_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2021.02.026","article-title":"The evolving landscape of biomarker testing for non-small cell lung cancer in Europe","volume":"154","author":"Kerr","year":"2021","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100560_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12916-015-0433-1","article-title":"Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries","volume":"13","author":"Kimman","year":"2015","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100560_bib48","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jtho.2020.04.024","article-title":"Lung cancer in Thailand","volume":"15","author":"Reungwetwattana","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 2","key":"10.1016\/j.esmoop.2022.100560_bib49","article-title":"Inequities of access, utilization and clinical outcome of lung cancer in Indonesia","volume":"4","author":"Ramadani","year":"2018","journal-title":"J\u00a0Global Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100560_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jtho.2019.10.021","article-title":"Lung cancer in Malaysia","volume":"15","author":"Rajadurai","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100560_bib51","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jtho.2020.11.020","article-title":"Lung cancer in Singapore","volume":"16","author":"Ang","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10147-008-0762-6","article-title":"The role of cancer registries in cancer control","volume":"13","author":"Parkin","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.esmoop.2022.100560_bib53","series-title":"Cancer registration: principles and methods. Statistical methods for registries","author":"Boyle","year":"1991"},{"key":"10.1016\/j.esmoop.2022.100560_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.33792","article-title":"Impact of the COVID-19 pandemic on population-based cancer registry","volume":"150","author":"Soerjomataram","year":"2021","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100560_bib55","doi-asserted-by":"crossref","first-page":"e1196","DOI":"10.1016\/S2214-109X(18)30386-3","article-title":"High-quality health systems in the Sustainable Development Goals era: time for a revolution","volume":"6","author":"Kruk","year":"2018","journal-title":"Lancet Global Health"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100560_bib56","first-page":"105","article-title":"Enhancing global access to cancer medicines","volume":"70","author":"Cortes","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100560_bib58","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-Magnitude of Clinical Benefit Scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100560_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000483","article-title":"Cancer medicines in Asia and Asia-Pacific: what is available, and is it effective enough?","volume":"4","author":"Eniu","year":"2019","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100560_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.31557\/APJCP.2020.21.5.1207","article-title":"An Asian body to tackle cancers in Asia\u2014The Asian National Cancer Centers Alliance","volume":"21","author":"Gatellier","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100560_bib61","first-page":"183","article-title":"Cancer control programs in East Asia: evidence from the\u00a0international literature","volume":"47","author":"Moore","year":"2014","journal-title":"J\u00a0Prev Med Public Health"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100560_bib62","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jtho.2020.05.002","article-title":"The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer","volume":"15","author":"Smeltzer","year":"2020","journal-title":"J\u00a0Thorac Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:27:52Z","timestamp":1761856072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2059702922001880"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100560","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100560"}}